| pubmed-article:20559739 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20559739 | lifeskim:mentions | umls-concept:C0006142 | lld:lifeskim |
| pubmed-article:20559739 | lifeskim:mentions | umls-concept:C1516213 | lld:lifeskim |
| pubmed-article:20559739 | lifeskim:mentions | umls-concept:C0431085 | lld:lifeskim |
| pubmed-article:20559739 | lifeskim:mentions | umls-concept:C1306673 | lld:lifeskim |
| pubmed-article:20559739 | lifeskim:mentions | umls-concept:C0449560 | lld:lifeskim |
| pubmed-article:20559739 | lifeskim:mentions | umls-concept:C0205221 | lld:lifeskim |
| pubmed-article:20559739 | lifeskim:mentions | umls-concept:C0205460 | lld:lifeskim |
| pubmed-article:20559739 | pubmed:issue | 12 | lld:pubmed |
| pubmed-article:20559739 | pubmed:dateCreated | 2010-12-2 | lld:pubmed |
| pubmed-article:20559739 | pubmed:abstractText | Triple receptor-negative breast cancers (TNBC) are higher grade and more likely to metastasize. Recurrences after 5 years are rare in TNBCs. Conversely, late recurrences are seen in estrogen receptor (ER)-positive (luminal) cancers. Disseminated tumor cells (DTCs) may be responsible for late recurrences. We compared rates of DTCs in basal and luminal subtypes. | lld:pubmed |
| pubmed-article:20559739 | pubmed:language | eng | lld:pubmed |
| pubmed-article:20559739 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20559739 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:20559739 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20559739 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20559739 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20559739 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:20559739 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:20559739 | pubmed:issn | 1534-4681 | lld:pubmed |
| pubmed-article:20559739 | pubmed:author | pubmed-author:KuererHenry... | lld:pubmed |
| pubmed-article:20559739 | pubmed:author | pubmed-author:HuntKelly KKK | lld:pubmed |
| pubmed-article:20559739 | pubmed:author | pubmed-author:BedrosianIsab... | lld:pubmed |
| pubmed-article:20559739 | pubmed:author | pubmed-author:Krishnamurthy... | lld:pubmed |
| pubmed-article:20559739 | pubmed:author | pubmed-author:LucciAnthonyA | lld:pubmed |
| pubmed-article:20559739 | pubmed:author | pubmed-author:Meric-Bernsta... | lld:pubmed |
| pubmed-article:20559739 | pubmed:author | pubmed-author:MosalpuriaKai... | lld:pubmed |
| pubmed-article:20559739 | pubmed:author | pubmed-author:LodhiAshutosh... | lld:pubmed |
| pubmed-article:20559739 | pubmed:author | pubmed-author:HallCarolynC | lld:pubmed |
| pubmed-article:20559739 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:20559739 | pubmed:volume | 17 | lld:pubmed |
| pubmed-article:20559739 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20559739 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20559739 | pubmed:pagination | 3252-8 | lld:pubmed |
| pubmed-article:20559739 | pubmed:meshHeading | pubmed-meshheading:20559739... | lld:pubmed |
| pubmed-article:20559739 | pubmed:meshHeading | pubmed-meshheading:20559739... | lld:pubmed |
| pubmed-article:20559739 | pubmed:meshHeading | pubmed-meshheading:20559739... | lld:pubmed |
| pubmed-article:20559739 | pubmed:meshHeading | pubmed-meshheading:20559739... | lld:pubmed |
| pubmed-article:20559739 | pubmed:meshHeading | pubmed-meshheading:20559739... | lld:pubmed |
| pubmed-article:20559739 | pubmed:meshHeading | pubmed-meshheading:20559739... | lld:pubmed |
| pubmed-article:20559739 | pubmed:meshHeading | pubmed-meshheading:20559739... | lld:pubmed |
| pubmed-article:20559739 | pubmed:meshHeading | pubmed-meshheading:20559739... | lld:pubmed |
| pubmed-article:20559739 | pubmed:meshHeading | pubmed-meshheading:20559739... | lld:pubmed |
| pubmed-article:20559739 | pubmed:meshHeading | pubmed-meshheading:20559739... | lld:pubmed |
| pubmed-article:20559739 | pubmed:meshHeading | pubmed-meshheading:20559739... | lld:pubmed |
| pubmed-article:20559739 | pubmed:meshHeading | pubmed-meshheading:20559739... | lld:pubmed |
| pubmed-article:20559739 | pubmed:meshHeading | pubmed-meshheading:20559739... | lld:pubmed |
| pubmed-article:20559739 | pubmed:meshHeading | pubmed-meshheading:20559739... | lld:pubmed |
| pubmed-article:20559739 | pubmed:meshHeading | pubmed-meshheading:20559739... | lld:pubmed |
| pubmed-article:20559739 | pubmed:year | 2010 | lld:pubmed |
| pubmed-article:20559739 | pubmed:articleTitle | Disseminated tumor cells in biologic subtypes of stage I-III breast cancer patients. | lld:pubmed |
| pubmed-article:20559739 | pubmed:affiliation | Department of Surgical Oncology, Unit 444, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. | lld:pubmed |
| pubmed-article:20559739 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:20559739 | pubmed:publicationType | Research Support, U.S. Gov't, Non-P.H.S. | lld:pubmed |
| pubmed-article:20559739 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
